Small molecule peptides with antioxidant effects

By combining the small molecule peptide SLLFPGGN or AFDAPIN isolated from Sichuan fermented sausages with Keap1 to activate the Keap1-Nrf2 signaling pathway, the problem of difficulty in alleviating the oxidative damage of INS-1 cells in the prior art is solved, and the antioxidant ability of cells is significantly improved. Reduced ROS and MDA levels and improved cell viability.

CN118620045BActive Publication Date: 2024-11-22CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410701369.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-05-31
Publication Date
2024-11-22
Estimated Expiration
2044-05-31

AI Technical Summary

Technical Problem

Existing antioxidants are difficult to effectively alleviate the oxidative damage of INS-1 cells induced by hydrogen peroxide, especially the key substances and mechanisms for improving oxidative damage in Lactobacillus SCS2 in fermented sausages in Sichuan.

Method used

The small-molecular peptide SLLFPGGN or AFDAPIN prepared from Lactobacillus plantarum SCS2 isolated from Sichuan fermented sausage activates the Keap1-Nrf2 signaling pathway through binding to Keap1, enhances the activity of antioxidant enzymes such as SOD, reduces ROS and MDA levels, and improves cellular oxidative damage by binding to Keap1, thereby enhancing the activity of antioxidant enzymes such as SOD, reducing ROS and MDA levels, and improving cellular oxidative damage. .

Benefits of technology

Small-molecule peptides PA and PB can significantly improve the expression of Nrf2, HO-1 protein and mRNA, enhance the cell's defense against oxidative damage, reduce the ROS and MDA levels in INS-1 cells, and improve cell viability and antioxidant enzyme activity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118620045B_ABST
    Figure CN118620045B_ABST
Patent Text Reader

Abstract

The present invention provides a small molecule peptide with antioxidant effect, which can alleviate hydrogen peroxide-induced INS-1 cell oxidative damage. The small molecule peptide is prepared from Lactobacillus plantarum with a deposit number of CGMCC No. 28395. The small molecule peptide of the present invention can activate the Keap1-Nrf2 signaling pathway by competitively binding to Keap1 with Nrf2, enhance the activity of major antioxidant enzymes such as SOD, reduce ROS and MDA levels, and thus improve INS-1 cell oxidative damage.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of functional polypeptide screening and application, and specifically relates to small molecule peptides with antioxidant effects. Background Art

[0002] Diabetes is a chronic disease characterized by abnormally high blood sugar levels, mainly caused by an absolute or relative deficiency of insulin secreted by pancreatic β cells. According to statistics from the International Diabetes Federation, diabetes has become the third most important non-communicable disease affecting human health worldwide, of which type 2 diabetes (T2DM) is the most common type. The pathogenesis of T2DM is very complex and has not yet been clarified, but as early as 2001, researchers proposed that oxidative damage is one of the key factors causing the occurrence and development of T2DM. When oxidative damage occurs, the amount of reactive oxygen species (ROS) and reactive nitrogen oxide (NO) free radicals produced in the body exceeds the normal level, and the degree of oxidation exceeds the body's ability to remove oxides, thereby promoting pancreatic β cell damage and increasing insulin resistance, ultimately exacerbating the development of T2DM. Therefore, improving the body's oxidative damage is of great significance for the prevention and treatment of T2DM.

[0003] When cells are stimulated by exogenous or endogenous oxidation, the generated ROS can activate multiple signal transduction pathways. Among them, the Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2-associated factor 2 (Nrf2) signaling pathway, as a key pathway in the endogenous antioxidant mechanism, plays an important regulatory role in maintaining the antioxidant defense mechanism. Under normal cell conditions, Keap1, as the main regulator of Nrf2 in the cytoplasm, binds to the ETGE and DLG amino acid sequences of Nrf2 through its Kelch domain to form a stable complex, thereby effectively regulating the activity of Nrf2. When cells are stimulated by external stimuli, Nrf2 is activated and dissociated from the complex, no longer ubiquitinated and degraded, and then enters the cell nucleus to bind to the antioxidant response element (ARE). This process promotes the transcription of phase II detoxification enzymes and antioxidant genes to enhance the cell's defense against oxidative damage.

[0004] As a safe and non-toxic potential antioxidant, lactic acid bacteria have achieved remarkable results in improving food safety and promoting health. These strains play a variety of physiological functions through active interactions with the host, including regulating the balance of intestinal flora, lowering blood cholesterol levels, and exhibiting strong antioxidant capacity. At present, studies have reported that heat-killed Lactobacillus rhamnosus can resist cell oxidative damage caused by ultraviolet radiation by increasing nuclear Nrf2 levels and superoxide dismutase (SOD) activity and reducing ROS content. Under oxidative stress conditions, the extracellular polysaccharides of Lactobacillus reuteri SJ-47 can have a certain protective effect on oxidatively damaged cells by reducing ROS and malondialdehyde (MDA) content and upregulating antioxidant enzyme expression. The research team's previous studies found that a strain of Lactobacillus plantarum SCS2 (derived from Sichuan fermented sausages Lactobacillus plantarum SCS2, L . plantarum SCS2) intracellular protein extract can improve oxidative damage in hyperglycemia model mice by increasing antioxidant enzyme activity and reducing ROS and MDA levels. L. plantarum The key substances and mechanisms in SCS2 intracellular protein extracts that improve oxidative damage are still unclear. Summary of the invention

[0005] The purpose of the present invention is to provide a small molecule peptide with antioxidant effect, which can alleviate the oxidative damage of INS-1 cells induced by hydrogen peroxide.

[0006] The present invention first provides a small molecule peptide with antioxidant effect, wherein the small molecule peptide is prepared from Lactobacillus plantarum with a deposit number of CGMCC No.28395;

[0007] Furthermore, the amino acid sequence of the small molecule peptide is SLLFPGGN (PA) or AFDAPIN (PB).

[0008] In yet another aspect, the present invention provides a use of the small molecule peptide described above, which is use in the preparation of antioxidant products.

[0009] The present invention also provides an antioxidant product, which contains the above-mentioned small molecule peptide;

[0010] Furthermore, in the antioxidant product, the concentration of the small molecule peptide PA is 0.1 mg / mL, and the concentration of the small molecule peptide PB is 0.05 mg / mL.

[0011] The small molecule peptide provided by the present invention can bind to Keap1, thereby increasing the expression of Nrf2, HO-1 protein and mRNA. The small molecule peptide of the present invention can activate the Keap1-Nrf2 signaling pathway by competitively binding to Keap1 with Nrf2, enhance the activity of major antioxidant enzymes such as SOD, reduce the levels of ROS and MDA, and thus improve INS-1 cell oxidative damage. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 :Sephadex G-25 separation L. plantarum Chromatogram of intracellular small peptide mixture ≤1 kDa in SCS2. Note: Results are expressed as mean ± standard deviation, n=3. * indicates significant difference compared with F2 group ( p <0.05);

[0013] Figure 2 : L. plantarum RP-HPLC chromatogram of the small peptide F2 component in SCS2 cells;

[0014] Figure 3 : L. plantarum Changes in DPPH free radical scavenging rate of different fractions of intracellular small molecule peptide F2 in SCS2. Note: Results are expressed as mean ± standard deviation, n=3. * indicates significant difference compared with Fg group ( p <0.05);

[0015] Figure 4 :MS / MS spectrum of SLLFPGGN (PA);

[0016] Figure 5 : MS / MS spectrum of AFDAPIN (PB);

[0017] Figure 6 :Molecular docking model of SLLFPGGN (PA) and Keap1;

[0018] Figure 7 : Molecular docking model of AFDAPIN (PB) and Keap1.

[0019] Figure 8 : L. plantarum Changes in INS-1 cell activity after treatment with SCS2 intracellular small molecule peptides. Results are expressed as mean ± standard deviation, and the number of parallel experiments is n=3. * indicates significant difference compared with the model group ( p <0.05, # indicates significant difference compared with the normal group ( p <0.05). NG: normal group, 0-3.2: different concentrations of small molecule peptide pretreatment + H 2 O 2Modeling treatment group.

[0020] Fig. 9 :Efficiency of Keap1 knockdown in INS-1 cells. Results are expressed as mean ± standard deviation, n=3. * indicates significant difference compared with the normal group ( p <0.05). NG: normal group, NCG: Negative Control siRNA experimental group, NSG: transfected siRNA Keap1 experimental group.

[0021] Fig.10 : Expression of Nrf2, Keap1 and HO-1 mRNA in INS-1 cells in each group after knockdown of Keap1. Results are expressed as mean ± standard deviation, n=3. * indicates significant difference compared with the model group ( p <0.05, # indicates significant difference compared with the normal group ( p <0.05), + indicates significant difference compared with PAG and PBG ( p <0.05). NG: normal group; NSG: siRNA Keap1 transfection group; MG: 60 μmol / LH 2 O 2 Model group; MSG: siRNA Keap1 transfection + 60 μmol / LH 2 O 2 Treatment group; NCG: Negative Control siRNA treatment group; PAG: 0.1 mg / mL PA+60 μmol / LH 2 O 2 Treatment group; PASG: siRNA Keap1 transfection + 0.1 mg / mL PA + 60 μmol / LH 2 O 2 Treatment group; PBG: 0.05 mg / mL PB + 60 μmol / LH 2 O 2 Treatment group; PBSG: siRNA Keap1 transfection + 0.05 mg / mL PB + 60 μmol / LH 2 O 2 Treatment group.

[0022] Fig.11 : Expression of Nrf2, Keap1 and HO-1 proteins in INS-1 cells in each group after knockdown of Keap1. Results are expressed as mean ± standard deviation, n=3. * indicates significant difference compared with the model group ( p <0.05, # indicates significant difference compared with the normal group ( p<0.05), + indicates significant difference compared with PAG and PBG ( p <0.05). NG: normal group; NSG: siRNAKeap1 transfection group; MG: 60 μmol / LH 2 O 2 Model group; MSG: siRNA Keap1 transfection + 60 μmol / LH 2 O 2 Treatment group; NCG: Negative Control siRNA treatment group; PAG: 0.1 mg / mL PA+60 μmol / LH 2 O 2 Treatment group; PASG: siRNA Keap1 transfection + 0.1 mg / mL PA + 60 μmol / LH 2 O 2 Treatment group; PBG: 0.05 mg / mL PB + 60 μmol / LH 2 O 2 Treatment group; PBSG: siRNA Keap1 transfection + 0.05 mg / mL PB + 60 μmol / LH 2 O 2 Treatment group.

[0023] Fig.12 :Nrf2 nuclear translocation of INS-1 cells in each group after knockdown of Keap1. The results are expressed as mean ± standard deviation, n=3. * indicates significant difference compared with the model group ( p <0.05, # indicates significant difference compared with the normal group ( p <0.05), + indicates significant difference compared with PAG and PBG ( p <0.05). The green part indicates Nrf2, and the blue part indicates INS-1 cell nucleus. NG: normal group; NSG: siRNA Keap1 transfection group; MG: 60 μmol / L H2O2 modeling group; MSG: siRNA Keap1 transfection + 60 μmol / L H 2 O 2 Treatment group; NCG: Negative Control siRNA treatment group; PAG: 0.1 mg / mL PA+60 μmol / LH 2 O 2 Treatment group; PASG: siRNA Keap1 transfection + 0.1 mg / mL PA + 60 μmol / LH 2 O 2 Treatment group; PBG: 0.05 mg / mL PB + 60 μmol / LH2 O 2 Treatment group; PBSG: siRNA Keap1 transfection + 0.05 mg / mL PB + 60 μmol / LH 2 O 2 Treatment group.

[0024] Fig.13 :Changes in ROS, MDA levels and activities of major antioxidant enzymes in INS-1 cells in each group. Results are expressed as mean ± standard deviation, n = 3. * indicates significant difference compared with the model group ( p <0.05, # indicates significant difference compared with the normal group ( p <0.05). NG: normal group; MG: 60 μmol / LH 2 O 2 Model group; PAG: 0.1 mg / mL PA+60 μmol / LH 2 O 2 Treatment group; PBG: 0.05 mg / mL PB + 60 μmol / LH 2 O 2 Treatment group. DETAILED DESCRIPTION

[0025] The present invention utilizes the separation of Sichuan fermented sausage L . plantarum SCS2, using dextran gel G25, reversed-phase high-performance liquid chromatography and tandem mass spectrometry to separate, purify and identify small molecule peptides with antioxidant effects. Through molecular docking, explore the binding of small molecule peptides with Keap1, and study whether small molecule peptides can play an antioxidant role through the Nrf2 / Keap1 pathway, thereby achieving the purpose of preventing type 2 diabetes.

[0026] The present invention embodiment uses the isolated from Sichuan fermented sausage L . plantarum SCS2 was deposited on September 8, 2023 at the General Microbiology Center of China Culture Collection Administration, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, with the deposit number CGMCC No.28395.

[0027] Example 1: From L . plantarum SCS2 preparation of intracellular small molecule peptide mixture

[0028] Under sterile conditions, L. plantarumSCS2 was inoculated in 100 mL MRS broth at a volume ratio of 0.5% and cultured at a constant temperature of 37°C for 24 h. At the end of the culture, the cells were centrifuged at 4°C and 10,000 r / min for 10 min, the supernatant was discarded and the cells were collected, resuspended in phosphate buffered saline (PBS), centrifuged at 10,000 r / min for 10 min, washed repeatedly 3 times, and the cells were collected again, aliquoted and placed in a -80°C ultra-low temperature refrigerator for use. The collected cells were resuspended in a sufficient volume of PBS buffer, the mixed solution was ultrasonically crushed for 20 min, and then centrifuged at 10,000 r / min for 10 min to obtain the supernatant. The supernatant was separated by an ultrafiltration centrifuge tube with a membrane molecular weight cutoff of 1 kDa, and the small molecular peptide component with a permeation component ≤1 kDa was collected, freeze-dried and stored at -20°C for use.

[0029] Weigh 100 g of Superdex G-25 dry gel particles and mix them with 3-5 times ultrapure water, then soak them at room temperature overnight to allow them to swell. After removing the broken gel, use a glass rod to introduce the treated dextran gel filler Superdex G-25 into the column. Avoid stratification, lines, and bubbles when filling the column. Take 1 g L. plantarum The intracellular small molecule peptide lyophilized powder of ≤1 kDa in SCS2 was prepared into a solution with a concentration of 100 mg / mL and filtered with a 0.45 μmol microporous filter membrane. The filtered sample was loaded into a Superdex G-25 gel filtration column with a sample volume of 3 mL and a flow rate of 0.5 mL / min. Ultrapure water was used as the eluent for elution, and the eluent was collected by an automatic collector during the process. The absorbance value of the eluent was measured at an ultraviolet wavelength of 215 nm. According to the absorbance measurement results, a single peak on the elution curve was selected for collection, and the collected sample was freeze-dried and used for later use.

[0030] The results are as follows Figure 1 As shown in the figure, after separation by Sephadex G-25, two component peaks were obtained, named F1 and F2. F1 component eluted before F2 component, and F2 component eluted later. Since there are pores of different sizes inside the dextran gel, large molecules cannot enter these pores and move faster in the chromatographic column, thus eluting before small molecules. Therefore, it can be explained that the molecular weight of F2 component is smaller. In addition, as Figure 1 As shown, the DPPH radical scavenging ability of the F2 fraction was higher than that of the F1 fraction ( p <0.05). Therefore, the results showed that the F2 fraction had a strong antioxidant capacity.

[0031] The collected F2 fraction was freeze-dried and dissolved in sterile water to prepare a 10 mg / mL solution. It was filtered using a 0.45 μmol microporous filter membrane. It was then purified using reversed phase high-performance liquid chromatography, and a single chromatographic peak was collected to obtain the purified L. plantarum SCS2 small molecule peptide. The chromatographic conditions are as follows: a PE C18 column (150 mm × 4.6 mm) was used, mobile phase A was pure water, and mobile phase B was acetonitrile solution containing 0.1% (v / v) trifluoroacetic acid; the injection volume was set to 30 μL; the column temperature was maintained at 25 ± 5 ℃; the flow rate was 1.0 mL / min; and the detection wavelength was 215 nm. During the entire gradient elution process, the ratio of mobile phase A and B was adjusted as follows: 0-8 min, phase A gradually decreased from 99% to 97%, and phase B increased from 1% to 3% accordingly; 8-12 min, phase A decreased from 97% to 96%, and phase B increased to 4%; 12-16 min, phase A decreased from 96% to 80%, and phase B increased to 20%; 16-20min, phase A recovered from 80% to 99%, and phase B decreased to 1%. The F2 component separated by G-25 dextran gel chromatography was separated by reversed-phase high performance liquid chromatography, and the results are shown in the figure. Figure 2 Nine elution peaks within 8-30 min were collected and named as F (a, b, c, d, e, f, g, h, i), and the area ratios of each elution peak to the total peak were 10.28%, 10.45%, 3.27%, 10.96%, 1.24%, 2.40%, 33.52%, 4.00% and 7.06%, respectively.

[0032] DPPH free radical scavenging assay was used to evaluate the L. plantarum Antioxidant capacity of each component of intracellular small molecule peptides of SCS2. Dissolve the lyophilized powder of each component in deionized water to prepare a sample solution of 3 mg / mL. Take 100 μL of the sample to be tested and mix it with 100 μL of 150 μmol / L DPPH-ethanol solution. Use the same volume of ultrapure water as the negative control group and the same volume of anhydrous ethanol as the blank group. The mixed solution was reacted at room temperature in the dark for 30 min, and its absorbance was measured at a wavelength of 518 nm.

[0033] The results are as follows Figure 3 As shown, L. plantarum Each small molecule component of SCS2 can effectively scavenge DPPH free radicals. Among them, the antioxidant capacity of Fg component is significantly higher than that of other components ( p <0.05). Therefore, the Fg component was selected for subsequent research.

[0034] Embodiment 2: L. plantarum Mass spectrometry identification and activity screening of SCS2 small molecule peptides

[0035] The small molecule peptide component Fg was dissolved in 100 μL of Nano-LC mobile phase A (containing 0.1% formic acid and 99.9% water) and placed in a sample vial for online LC-MS-MS analysis. The dissolved sample solution was injected with a volume of 2 μL and entered into a nano ViperC18 pre-column (150 mm×75 μm, 100 Å pore size) for pre-desalting. Subsequently, the desalted sample was separated by a C18 reverse phase column (250 mm×75 μm, 100 Å pore size) and a 30-minute gradient was set, in which the mobile phase B (containing 80% acetonitrile, 0.1% formic acid and 19.9% ​​deionized water) increased from 5% to 38%. During mass spectrometry analysis, the spray voltage was set to 1.9 kV, the ion transfer tube was heated to 275 °C, the acquisition mode was data-dependent acquisition (DDA), the primary mass spectrometry resolution was set to 70,000, the scanning range was 100-1500 m / z, the maximum injection time was 100 ms, the maximum injection time of the secondary mass spectrometry was 50 ms, the energy of high-energy collision-induced dissociation was set to 28 eV, and the dynamic exclusion time was set to 6 s to avoid repeated acquisition. The collected raw spectrum files were processed and searched using PEAKS Studio 8.5 software. The database was the plant lactobacillus species protein database downloaded by Uniprot. The search parameters were set as follows: the primary mass spectrometry mass tolerance was 10 ppm, and the secondary mass spectrometry was 0.05 Da. The variable modifications were Oxidation (M), Acetylation (Protein N-term), Deamidation (NQ), Pyro-glu from E, and Pyro-glu from Q.

[0036] The results showed that 53 small molecule peptides were obtained from the polypeptide sequence of the Fg component, with a molecular weight distribution range of 0.4-1.1 kDa. -101gP greater than 15 was used as a reliable result, and the -101gP of the 53 small molecule peptides was greater than 15.

[0037] This study used the PeptideRanker method to evaluate the bioactivity of peptides. The tool can be accessed through the link http: / / distilldeep.ucd.ie / PeptideRanker / . PeptideRanker predicts the potential of small molecule peptides as bioactive peptides by analyzing their structural features and assigns a score ranging from "0" to "1" to each small molecule peptide. The higher the score, the more likely the small molecule peptide is to have bioactivity. In this study, the threshold of the PeptideRanker score was set to 0.5, and small molecule peptides exceeding this threshold were more likely to show bioactivity. Through PeptideRanker scoring screening, a total of 13 small molecule peptides were found to have scores exceeding 0.5 and molecular weights between 0.4-0.8kDa, indicating that these small molecule peptides may have high bioactivity.

[0038] Screening of molecules that can bind to Keap1 protein by molecular docking L. plantarum SCS2 small molecule peptide. The three-dimensional structure of Keap1 protein (PDB ID: 7K2A) was downloaded from the Protein Data Bank (PDB, http: / / www.rcsb.org) for designing docking site boxes. PyMOL 2.3.0 software was used to remove water molecules, irrelevant protein chains and original ligands in the structure to prepare for docking. The 3D structure of the ligand was optimized by the MMFF94 force field of OpenBabel 3.1.1 software, and the docking center coordinates (x: -42.1, y: 23.5, z: 60.8) and the box size (17.6×17.6×24.7) were set. The three-dimensional structure of the small molecule peptide was constructed using Chem3D software, and the Lamarckian genetic algorithm was used for docking through semi-flexible docking. The docking accuracy was set to exhaustiveness=25. Auto Dock Vina1.2.0 was run to obtain the docking binding free energy and docking result files. The higher the absolute value of the docking score, the stronger the interaction between the ligand and the receptor.

[0039] Studies have shown that when the binding energy is less than 0 kcal / mol, it means that the receptor and ligand bind spontaneously without external energy; when the binding energy is less than -5 kcal / mol, it means that the affinity between the ligand and the receptor is strong; when the binding energy is less than -7.2 kcal / mol, it means that there is a strong binding affinity between the ligand and the receptor. The results show that the binding energy of the 13 small molecule peptides obtained with the Keap1 protein is less than -5 kcal / mol, indicating that these small molecule peptides have a strong binding affinity with the Keap1 protein.

[0040] It is worth noting that the natural binding energy between Nrf2 and Keap1 is -6.9 kcal / mol. The results of this study showed that the small molecule peptide AFDAPIN has the most significant binding with Keap1, while the small molecule peptide SLLFPGGN has the same binding energy as Nrf2. Therefore, the small molecule peptide SLLFPGGN (PA) and the small molecule peptide AFDAPIN (PB) were selected for subsequent research. Among them, the secondary mass spectrum of the small molecule peptide PA is shown in Figure 4 As shown, the secondary mass spectrum of small molecule peptide PB is as follows Figure 5 The molecular docking model of small molecule peptide PA and Keap1 is shown in Figure 6 As shown in the figure, the molecular docking model of small molecule peptide PB and Keap1 is shown in Figure 7 shown.

[0041] Embodiment 3: L. plantarum Effects of SCS2 intracellular small molecule peptide on oxidative damage in INS-1 cells

[0042] INS-1 cells were seeded in 96-well plates and cultured for 24 h. L. plantarum INS-1 cells were pretreated with SCS2 intracellular small molecule peptide (0.025-3.2 mg / mL) for 24 h and then treated with 60 μmol / L H 2 O 2 The intervention lasted for 24 h. The cells in the control group were treated with an equal volume of RPMI 1640 complete medium. After the treatment, the old medium was removed, the cells were washed twice with PBS buffer, 10 μL of CCK-8 reagent was added to each well, and the cells were incubated at 37°C in the dark for 2 h. The absorbance of each well was measured at a wavelength of 450 nm.

[0043] The results are as follows Figure 8 As shown in Figure 2, when the concentration of small molecule peptide PA was 0.1 mg / mL, the cell viability was significantly increased compared with the model group ( p <0.05). When the concentration of small molecule peptide PB was 0.05 mg / mL, the cell viability was significantly increased compared with the model group and was the highest ( p <0.05).

[0044] Embodiment 4: L. plantarum The mechanism of SCS2 intracellular small molecule peptide improving oxidative damage in INS-1 cells

[0045] INS-1 cells were seeded in 6-well plates and transfected after culturing in RPMI 1640 complete medium for 24 h. 100 μL of RPMI 1640 medium containing 7.5 μg LipoMax was aspirated and thoroughly mixed with 100 μL of RPMI 1640 medium containing 2.5 μg siRNA Keap1. The mixture was allowed to stand at room temperature for 10 min to form a stable siRNA-LipoMax complex, which was then added to the 6-well plate and the cells were incubated with the complex for 24 h and 48 h. In order to evaluate the possible effects of the transfection process on the cells and to ensure the accuracy and reliability of the experimental results, a plasmid containing the same concentration of nonspecific Negative Control siRNA was set up as a control group. The expression level of the Keap1 gene was detected by RT-qPCR technology to verify the efficiency of Keap1 gene silencing. The results are shown in Figure 2. Fig. 9 As shown, there was no significant difference in the expression level of Keap1 gene between the NG and NSG groups 24 h after siRNA Keap1 transfection ( p >0.05). However, when the transfection time reached 48 h, the Keap1 gene expression level in the NSG group was significantly decreased compared with that in the NG and NCG groups ( p <0.05), indicating that 48 h is the effective transfection time for knocking down Keap1.

[0046] For further exploration L. plantarum Whether the regulation of Nrf2 expression by intracellular small molecule peptides PA and PB in SCS2 depends on Keap1 was verified at the gene and protein levels by RT-qPCR experiments.

[0047] INS-1 cells were seeded in 6-well plates and cultured for 24 h before transfection. L. plantarum INS-1 cells were pretreated with SCS2 intracellular small molecule peptides and then treated with 60 μmol / L H 2 O 2 The cells were treated for 24 h to induce oxidative damage, and the control group cells were treated with an equal volume of RPMI 1640 complete medium. Total RNA was extracted using a total cell RNA isolation kit. After confirming that the concentration and purity of the RNA sample met the requirements, the sample was reverse transcribed into cDNA using a first-strand cDNA synthesis kit. Subsequently, an RT-qPCR reaction system was prepared, and RT-qPCR was used to quantitatively analyze gene expression.

[0048] The results are as follows Fig.10 As shown in Figure 2, compared with the NG group, the expression levels of Nrf2 and HO-1 genes in the MG group were significantly decreased, and the expression level of Keap1 gene was significantly increased ( p<0.05). Compared with the MG group, the expression levels of Nrf2 and HO-1 genes in the PAG and PBG groups were significantly increased, and the expression level of Keap1 gene was significantly decreased ( p <0.05). Compared with the MSG group, there was no significant difference in the expression levels of Nrf2 and HO-1 genes in the PASG and PBSG groups ( p >0.05), compared with the PAG and PBG groups, the expression levels of Nrf2, HO-1 and Keap1 genes in the PASG and PBSG groups were significantly decreased ( p <0.05). The above results show that L. plantarum SCS2 intracellular small molecule peptides PA and PB effectively improved oxidative damage in INS-1 cells by regulating Nrf2 levels and activating antioxidant enzyme activity, and this process depended on the participation of Keap1.

[0049] INS-1 cells were seeded in 6-well plates and cultured in RPMI 1640 complete medium for 24 h before transfection. L. plantarum INS-1 cells were pretreated with SCS2 intracellular small molecule peptides, and the cells were stimulated with 60 μmol / L H2O2 for 24 h to induce oxidative damage in INS-1 cells. The control group cells were treated with an equal volume of RPMI 1640 complete medium. After treatment, the cells were collected and lysate was added to extract total protein. The samples were separated by 10% SDS-PAGE electrophoresis, and then the proteins were transferred to PVDF membranes by electrotransfer. After the PVDF membrane was blocked in 5% skim milk at room temperature for 2 h, it was incubated with specific primary antibodies (Nrf2, Keap1, HO-1, GAPDH) overnight. After the primary antibody incubation was completed, the PVDF membrane was incubated with the secondary antibody at room temperature for 1 h. The protein bands were detected by chemiluminescence development, and the gray value of the bands was quantitatively analyzed by Image J software.

[0050] Previous molecular docking results showed that L. plantarum SCS2 intracellular small molecule peptides PA and PB have strong binding ability with Keap1. To further explore whether PA and PB regulate the accumulation and incorporation of Nrf2 protein into the nucleus through Keap1 protein, this experiment specifically knocked down Keap1 expression in INS-1 cells. Fig.11 As shown in Figure 2, compared with the NG group, the expression levels of Nrf2 and HO-1 proteins in the MG group were significantly decreased, and the expression level of Keap1 protein was significantly increased ( p <0.05). Compared with the MG group, the expression levels of Nrf2 and HO-1 proteins in the PAG and PBG groups were significantly increased, and the expression level of Keap1 protein was significantly decreased ( p<0.05). However, there was no significant difference in the expression levels of Nrf2 and HO-1 proteins in the PASG and PBSG groups compared with the MSG group ( p >0.05). Compared with the PAG and PBG groups, the expression levels of Nrf2, HO-1 and Keap1 proteins in the PASG and PBSG groups were significantly decreased ( p <0.05). This result shows that L. plantarum SCS2 intracellular small molecule peptides PA and PB can regulate the expression level of Nrf2 protein and activate the expression of downstream antioxidant enzymes, and this process may depend on the participation of Keap1 protein.

[0051] INS-1 cells were seeded in 24-well plates and cultured for 24 h. L. plantarum INS-1 cells were pretreated with SCS2 intracellular small molecule peptides, and cell oxidative damage was induced by H2O2. The control group cells were treated with an equal volume of RPMI 1640 complete medium. After treatment, the cells were fixed with 4% paraformaldehyde preheated at 37°C for 15 min at room temperature. The fixative was removed by aspiration, washed 3 times with PBS buffer, and 200 μL of 0.5% Triton×100 permeabilization solution was added to each well and incubated at room temperature for 15 min. After aspirating the permeabilization solution, the cells were washed 3 times with PBS buffer, and 200 μL of 1% BSA was added to each well and incubated at room temperature for 2 h. After aspirating the blocking solution, the cells were washed 3 times with PBS buffer, and 200 μL of Nrf2 primary antibody working solution diluted with 1% BSA (dilution ratio of 1:150) was added, and incubated overnight at 4°C on a shaker. After recovering the primary antibody, wash with PBS buffer for 3 times, 5 min each time, add 200 μL of secondary antibody working solution (dilution ratio of 1:500) to each well, and incubate at room temperature for 2 h in the dark. Wash with PBS buffer again for 3 times, 5 min each time, add 100 μL of DAPI working solution to each well, incubate at 4°C in the dark for 10 min, and then observe and take pictures under a fluorescence microscope.

[0052] The results are as follows Fig.12 As shown, compared with the NG group, the level of Nrf2 fluorescence intensity in the nucleus of the MG group was significantly decreased ( p <0.05), indicating that H 2 O 2 The induced oxidative damage led to a decrease in the accumulation of Nrf2 in the nucleus. Compared with the MG group, the nuclear Nrf2 fluorescence intensity levels in the PAG and PBG groups were significantly increased ( p <0.05). However, there was no significant difference in the nuclear Nrf2 fluorescence intensity levels in the PASG and PBSG groups compared with the MSG group ( p>0.05). Compared with the PAG and PBG groups, the fluorescence intensity of Nrf2 in the nucleus of the PASG and PBSG groups was significantly decreased ( p <0.05). The results showed that L. plantarum SCS2 intracellular small molecule peptides PA and PB can promote the nuclear translocation of Nrf2 in oxidatively damaged INS-1 cells, and this process may be achieved by relying on Keap1.

[0053] Embodiment 5: L. plantarum Effects of SCS2 intracellular small molecule peptide on ROS, MDA levels and activities of major antioxidant enzymes in INS-1 cells

[0054] INS-1 cells were seeded in 6-well plates and cultured for 24 h. L. plantarum INS-1 cells were pretreated with SCS2 intracellular small molecule peptide for 24 h, and then 2 O 2 To induce cellular oxidative damage, cells in the control group were treated with an equal volume of RPMI 1640 complete medium. After treatment, 10 μmol / L DCFH-DA fluorescent probe was added to each well and incubated at 37°C in the dark for 30 min. After incubation, the medium was aspirated, the cells were washed with PBS buffer, and finally the cells were collected and analyzed by flow cytometry (excitation wavelength: 488 nm, emission wavelength: 525 nm).

[0055] INS-1 cells were seeded in 6-well plates and cultured for 24 h. L. plantarum INS-1 cells were pretreated with SCS2 intracellular small molecule peptide for 24 h, and then 2 O 2 Induce oxidative damage in INS-1 cells, and the control group cells were treated with an equal volume of RPMI 1640 complete medium. After treatment, the cells were washed and collected with PBS buffer, and then added with lysis buffer for cell lysis. After incubation on ice for 30 min, the supernatant was collected by centrifugation at 10000 r / min for 10 min at 4°C. The corresponding ELISA detection kits were used to detect the levels of MDA, SOD, CAT and GPx in the cells according to the instructions provided by the manufacturer.

[0056] result Fig.13 As shown in the figure, compared with the NG group, the levels of ROS and MDA in the MG group were significantly increased, and the activities of major antioxidant enzymes such as SOD, catalase (CAT) and glutathione peroxidase (GPx) were significantly inhibited ( p<0.05). Compared with the MG group, the levels of ROS and MDA in the PAG and PBG groups were significantly decreased, and the activities of major antioxidant enzymes such as SOD, CAT and GPx were significantly increased ( p <0.05). The results showed that L. plantarum SCS2 intracellular small molecule peptides PA and PB can improve oxidative damage of INS-1 cells by enhancing the activity of major antioxidant enzymes such as SOD and reducing the levels of ROS and MDA.

[0057] In summary, through dextran gel chromatography, RP-HPLC, LC-MS / MS and Peptideranker and other methods, L. plantarum Thirteen small peptides with strong antioxidant activity were screened from the mixture of intracellular small peptides ≤1 kDa in SCS2. L. plantarum SCS2 intracellular small molecule peptide can inhibit the interaction between Keap1 and Nrf2 by competitively binding to Keap1 with Nrf2, thereby activating the Keap1-Nrf2 pathway, enhancing the activity of major antioxidant enzymes such as SOD, reducing the levels of ROS and MDA, and improving the oxidative damage of INS-1 cells.

Claims

1. A small molecule peptide with antioxidant effect, characterized in that: The small molecule peptide is prepared from plant lactobacillus with a preservation number of CGMCC No. 28395; the amino acid sequence of the small molecule peptide is SLLFPGGN or AFDAPIN.

2. Use of the small molecule peptide according to claim 1 in the preparation of antioxidant products.

3. An antioxidant product, characterized in that: The product contains the small molecule peptide according to claim 1.

4. The antioxidant product according to claim 3, characterized in that The amino acid sequence of the small molecule peptide is SLLFPGGN, and its concentration is 0.1 mg / mL.

5. The antioxidant product according to claim 3, characterized in that The amino acid sequence is a small molecule peptide of AFDAPIN, and its concentration is 0.05 mg / mL.